The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03252938
Brief Title: Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors

First Submitted : August 14, 2017
First Submitted that Met QC Criteria : August 14, 2017
First Posted : August 17, 2017

Last Update Submitted that Met QC Criteria : March 5, 2024
Last Update Posted : March 6, 2024